The effect of NLRP inflammasome on the regulation of AGEs-induced inflammatory response in human periodontal ligament cells.

BACKGROUND AND OBJECTIVE Diabetes influences the frequency and development of periodontitis. Inflammation of human periodontal ligament cells (HPDLCs) participates in this pathologic process. Hence, this study aims to explore whether advanced glycation end products (AGEs), by-products of diabetes, could exaggerate inflammation induced by muramyl dipeptide (MDP) in HPDLCs, and whether nucleotide-binding oligomerization domain-like receptors (NLRs) signaling pathway was involved. MATERIAL AND METHODS Human periodontal ligament cells were pre-treated with 100 μg/mL AGEs for 24 hours and stimulated with 10 μg/mL MDP for 24 hours. IL-6, IL-1β, and RAGE were detected, and the activation of NF-κB signaling pathway was observed. The expression of NLRs was evaluated with or without silencing RAGE or blocking NF-κB pathway under AGEs stimulation. Statistical analyses were performed by using independent sample t test. RESULTS Advanced glycation end products induced significant increase of inflammatory cytokines in HPDLCs (P < 0.05). Results of western blot (WB) showed that after 45 minutes stimulation of AGEs, p-p65/p65 ratio peaked; AGEs promoted the expression of NLRP1, NLRP3, and apoptosis-associated speck-like protein containing a CARD (ASC). After silencing RAGE or blocking NF-κB pathway, the up-regulation of NLRs protein caused by AGEs was attenuated. Additionally, AGEs pre-treatment could enhance the inflammatory response of MDP and the expression of NLRs, which were demonstrated by more expression of IL-6, IL-1β, NOD2, NLRP1, NLRP3, and ASC. CONCLUSION Advanced glycation end products induced inflammatory response in HPDLCs via NLRP1-inflammasome and NLRP3-inflammasome activation in which NF-κB signal pathway was involved. Besides, AGEs promoted the inflammatory response of MDP via NOD2, NLRP1-inflammasome, and NLRP3-inflammasome.

[1]  C. Scavone,et al.  Hyperglycemia induces inflammatory mediators in the human chorionic villous , 2018, Cytokine.

[2]  S. Paul,et al.  RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review , 2018, Hormones and Cancer.

[3]  Mingfu Wang,et al.  4′-Methoxyresveratrol Alleviated AGE-Induced Inflammation via RAGE-Mediated NF-κB and NLRP3 Inflammasome Pathway , 2018, Molecules.

[4]  E. Coto,et al.  Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function. , 2018, Human immunology.

[5]  T. Santa-Coloma,et al.  N-acetyl cysteine reverts the proinflammatory state induced by cigarette smoke extract in lung Calu-3 cells , 2018, Redox biology.

[6]  D. Graves,et al.  Diabetes Activates Periodontal Ligament Fibroblasts via NF-κB In Vivo , 2018, Journal of dental research.

[7]  S. Ghavami,et al.  Inflammasomes and type 2 diabetes: An updated systematic review. , 2017, Immunology letters.

[8]  Jeon-Soo Shin,et al.  Advanced glycation end products impair NLRP3 inflammasome–mediated innate immune responses in macrophages , 2017, The Journal of Biological Chemistry.

[9]  X. Zhou,et al.  NLRP3 inflammasome may regulate inflammatory response of human periodontal ligament fibroblasts in an apoptosis‐associated speck‐like protein containing a CARD (ASC)‐dependent manner , 2017, International endodontic journal.

[10]  J. Slots.  Periodontitis: facts, fallacies and the future. , 2017, Periodontology 2000.

[11]  F. Huang,et al.  NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy , 2017, Front. Physiol..

[12]  Xinghuo Wu,et al.  Advanced glycation end products regulate anabolic and catabolic activities via NLRP3‐inflammasome activation in human nucleus pulposus cells , 2017, Journal of cellular and molecular medicine.

[13]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[14]  M. Nitti,et al.  RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage , 2016, Oxidative medicine and cellular longevity.

[15]  Jung Jae Shin,et al.  Damage-associated molecular patterns and their pathological relevance in diabetes mellitus , 2015, Ageing Research Reviews.

[16]  J. Meyle,et al.  Local inflammatory reactions in patients with diabetes and periodontitis. , 2015, Periodontology 2000.

[17]  A. Janež,et al.  NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients , 2015, Journal of diabetes research.

[18]  S. Kang,et al.  Muramyl dipeptide activates human beta defensin 2 and pro-inflammatory mediators through Toll-like receptors and NLRP3 inflammasomes in human dental pulp cells , 2015, Clinical Oral Investigations.

[19]  R. Vance,et al.  The NLRP1 inflammasomes , 2015, Immunological reviews.

[20]  L. Joosten,et al.  Inflammasome-independent regulation of IL-1-family cytokines. , 2015, Annual review of immunology.

[21]  H. Chen,et al.  Advanced glycation end products upregulate the endoplasmic reticulum stress in human periodontal ligament cells. , 2015, Journal of periodontology.

[22]  J. Ke,et al.  Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[23]  S. Eschenburg,et al.  Crystal structure of the leucine‐rich repeat domain of the NOD‐like receptor NLRP1: Implications for binding of muramyl dipeptide , 2014, FEBS letters.

[24]  P. Popovich,et al.  Pattern recognition receptors and central nervous system repair , 2014, Experimental Neurology.

[25]  Jing Shi,et al.  Nod-Like Receptor Protein 1 Inflammasome Mediates Neuron Injury under High Glucose , 2014, Molecular Neurobiology.

[26]  C. Zhang,et al.  Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model , 2014, Cardiovascular Drugs and Therapy.

[27]  D. H. Sumida,et al.  Apical periodontitis and periodontal disease increase serum IL-17 levels in normoglycemic and diabetic rats , 2014, Clinical Oral Investigations.

[28]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[29]  Li-Ying Chien,et al.  Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide. , 2013, Journal of periodontal research.

[30]  C. Glass,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[31]  T. Nishida,et al.  Cytokine and Chemokine Secretion Induced by Poly(I:C) through NF-κB and Phosphoinositide 3-Kinase Signaling Pathways in Human Corneal Fibroblasts , 2013, Current eye research.

[32]  Youhua Liu,et al.  AGE-LDL Activates Toll Like Receptor 4 Pathway and Promotes Inflammatory Cytokines Production in Renal Tubular Epithelial Cells , 2013, International journal of biological sciences.

[33]  M. Shong,et al.  Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes , 2012, Diabetes.

[34]  F. Hu,et al.  Type 2 diabetes mellitus and 20 year incidence of periodontitis and tooth loss. , 2012, Diabetes research and clinical practice.

[35]  G. Umpierrez,et al.  Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. , 2012, Journal of diabetes and its complications.

[36]  Xuedong Zhou,et al.  Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts. , 2011, Archives of oral biology.

[37]  N. Ishiguro,et al.  Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees , 2011, Inflammation Research.

[38]  Z. Mollah,et al.  NF-κB in type 1 diabetes. , 2011, Inflammation & allergy drug targets.

[39]  C. Gabay,et al.  IL-1 pathways in inflammation and human diseases , 2010, Nature Reviews Rheumatology.

[40]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[41]  L. Joosten,et al.  IL-1β Processing in Host Defense: Beyond the Inflammasomes , 2010, PLoS pathogens.

[42]  V. Nizet,et al.  A NOD2–NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide , 2008, Proceedings of the National Academy of Sciences.

[43]  N. Volkmann,et al.  Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.

[44]  J. Bertin,et al.  Distinct Roles of TLR2 and the Adaptor ASC in IL-1β/IL-18 Secretion in Response to Listeria monocytogenes1 , 2006, The Journal of Immunology.

[45]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[46]  O. P. Kalra,et al.  Role of advanced glycation end products ( AGEs ) – induced receptor ( RAGE ) expression in diabetic vascular complications , 2014 .